Biopharmaceutical Third-Party Logistics Market Players:
- Agility Logistics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AmerisourceBergen Corporation
- DB Schenker
- DHL International GmbH
- FedEx Corporation
- Kerry Logistics Network Limited
- Kuehne + Nagel International AG
- McKesson Corporation
- SF Express Co. Ltd.
- United Parcel Service of America, Inc.
Companies play a vital role in fostering the growth of the market, by introducing innovations and developments. In the biopharmaceutical third-party logistics market companies have revolutionized storage and transportation services by ensuring regulatory compliance and product safety. The market consists of several global and regional key players focused on adopting several strategies such as mergers and acquisitions, product launches, partnerships, and joint ventures to retain their market position and enhance their product base.
The eminent contributors in the industry include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of biopharmaceutical third-party logistics is assessed at USD 159.21 billion.
The global biopharmaceutical third-party logistics market size was valued at over USD 150.28 billion in 2025 and is expected to expand at a CAGR of over 6.6%, surpassing USD 284.76 billion revenue by 2035.
North America biopharmaceutical third-party logistics market will account for 42.30% share by 2035, driven by a strong biopharmaceutical industry, advanced infrastructure, and regulatory compliance.
Key players in the market include DHL Supply Chain, FedEx Corporation, United Parcel Service, Inc. (UPS), Kuehne+Nagel International AG, DB Schenker, CEVA Logistics, XPO Logistics, Inc., Nippon Express Co., Ltd., Panalpina World Transport (Holding) Ltd., Yusen Logistics Co., Ltd.
